IntegriChain announced the acquisition of Medical Communication Technologies (MCT). MCT is a provider of government pricing and contracting software and services. IntegriChain will integrate MCT's government pricing SaaS platform into its ICyte data platform, creating an offering for bio/pharma manufacturers. This acquisition adds 35+ new brand and generic bio/pharma manufacturer customers to IntegriChain's customer base and is the company's second acquisition since entering its strategic partnership with Accel-KKR, a leading technology-focused private equity firm, in 2016.
"This acquisition offers the unique opportunity to integrate MCT's government pricing software into ICyte's data management foundation," said IntegriChain Co-Founder and CEO Kevin Leininger. "Data management is one of the biggest sources of cost and complexity in government contract management, and we believe the combination of our two companies' services represents a unique opportunity to streamline highly compliance-sensitive business processes in pharmaceutical contracting and pricing."